AudioKey 3 vs CIQOL

The AudioKey 3 mobile app from MED-EL can be used as a remote control for supported MED-EL audio processors which are SONNET (EAS), SONNET 2 (EAS), SONNET 3 (EAS), and RONDO 3. Additionally, AudioKey 3 lets you customize personal settings, such as the names of programs on the audio processors. AudioKey 3 can be used by caregivers to support other users, such as young children. You can use the Find My Processor functionality to help locate lost or misplaced audio processors. AudioKey 3 also lets you check the usage statistics of the connected audio processors and quickly access helpful support material from MED-EL. If you own a MED-EL streaming device, you can configure it with AudioKey 3.

The Cochlear Implant Quality of Life (CIQOL) Digital Platform is a revolutionary tool designed to improve the care and outcomes of cochlear implant (CI) users. This innovative platform consists of two main components: the CIQOL App for patients and the CIQOL Clinical Web Portal for healthcare professionals. Built on a foundation of comprehensive research and developed using a User-Centered Design approach, this platform empowers both patients and clinicians by offering a streamlined, efficient way to monitor CI-related outcomes. The CIQOL Digital Platform is the result of years of research focused on understanding and improving the cochlear implant experience. It provides patients with easy-to-complete assessments before and after surgery, while clinicians benefit from automated scoring, data comparisons, and interpretation that can help guide clinical care. Key Features: 1. Pre-Cochlear Implant Evaluation: Patients complete key components of the evaluation process before arriving at the clinic, saving time and enhancing the assessment process. These include: - Patient intake section, gathering demographics and hearing history. - CIQOL outcome expectations assessment with automated scoring, compared to data from over 700 experienced CI users. - Baseline pre-CI CIQOL-35 Profile assessment with automated scoring and comparison to normative CIQOL data. 2. Post-Cochlear Implant Monitoring: The platform enables ongoing, automated monitoring at 1, 3, 6, and 12-month intervals post-surgery. Patients complete the CIQOL-35 Profile at these intervals, and results are: - Automatically compared to baseline scores. - Analyzed to determine whether improvements exceed the minimal detectable change threshold. - Linked to speech recognition scores for a holistic view of patient progress. 3. Automated Scoring and Interpretation: The platform eliminates manual calculations by automatically generating scores for both pre- and post-implant assessments. Clinicians receive detailed insights, including comparisons to normative data and interpretation of patient progress over time. 4. User-Friendly Interface: Patients and clinicians access the platform through either a mobile app or web-based portal. The intuitive design allows patients to track their progress and engage in their care, while clinicians can view comprehensive reports that aid in decision-making. 5. Evidence-Based Design: The platform was created following extensive interviews with cochlear implant audiologists, speech-language pathologists, surgeons, and CI users. This ensures that the content and features meet the needs of both patients and clinicians while overcoming common barriers to implementation in real-world clinical settings. By using the CIQOL Digital Platform, clinicians can more effectively track patient progress and make data-driven decisions, while patients enjoy a more streamlined and personalized care experience. Whether pre- or post-implant, the CIQOL Digital Platform provides the tools needed to enhance the quality of life for cochlear implant users, ensuring optimal care at every step of the journey.